Study of effect of saroglitazar on metabolic parameters in patients with type 2 diabetic dyslipidemia.
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Saroglitazar (Primary)
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 19 Sep 2016 New trial record